Acerus currently has licensed marketing partners in over 71 countries, including Canada, and working to diversify revenue across meaningful markets globally.

Acerus continues to pursue business development opportunities that align with our therapeutic focus in Men’s Health (Urology and Andrology). However, we are open to consideration of opportunities in other complimentary therapeutic areas.

We also have an interest in partnership with third parties in jurisdictions outside of Canada that have the requisite expertise in marketing pharmaceutical products, as well as sufficient resources to effectively commercialize our products at a favourable value inflection point for each of our pipeline programs.

Become a Partner

Acerus offers in-house expertise at all stages of the pharmaceutical product lifecycle, from clinical and regulatory competency to full commercialization capabilities.

For more information on partnership opportunities with Acerus, please contact us at

Acerus currently has partnerships in the following regions for the Licensed Brand Natesto®

  • Signed
  • Filing Under Prep.
  • Approved
Region Licensed Brand Status
Aytu Aytu
United States NATESTO® Approved
Hyundai Hyundai South Korea NATESTO® Approved
Medac Medac 28 current EU member countries (including the United Kingdom) as well as Norway, Liechtenstein, Iceland, Turkey (including Turkish Cyprus), Australia, New Zealand, Israel and South Africa NATESTO®
Carnot Carnot Mexico NATESTO® Filing under prep.
Carnot Carnot South America NATESTO® Filing under prep.
Apsen Apsen Brazil NATESTO® Filing under prep.
Therios Therios Egypt, UAE and Saudi Arabia NATESTO® Filing under prep.
EU HWA EU HWA Asia Pacific NATESTO® Filing under prep.

*First 21 EU countries under DCP. See our Press Release.